PHI with juvenile diabetes
How does this condition affect your private health insurance?
Diabetes juvenilis, more commonly known as Type 1 Diabetes, is an autoimmune condition where the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. This results in little to no insulin production, a hormone essential for regulating blood sugar. It typically manifests in childhood or adolescence, though it can occur at any age. Symptoms often develop rapidly and include excessive thirst, frequent urination, unexplained weight loss, and fatigue. Management involves lifelong insulin therapy via injections or an insulin pump, meticulous blood sugar monitoring, and dietary adjustments to prevent acute complications like diabetic ketoacidosis and long-term health issues affecting the heart, kidneys, eyes, and nerves.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to several weeks
Duration of Illness (Lifetime)
Lifelong chronic condition
Cost of Treatment (Initial)
High (initial diagnosis, hospitalization, insulin, supplies, education, e.g., several thousands to tens of thousands USD)
Cost of Treatment (Lifetime)
Very high (continuous insulin, supplies, monitoring devices, regular medical appointments, management of complications, e.g., hundreds of thousands USD over a lifetime)
Mortality Rate
Low with proper management, but possible due to acute complications (e.g., DKA) or severe long-term complications. Untreated, it is fatal.
Risk of Secondary Damages
High (e.g., retinopathy, nephropathy, neuropathy, cardiovascular disease, if blood sugar is not well-controlled)
Probability of Full Recovery
Virtually 0% (currently, Type 1 Diabetes is incurable)
Underlying Disease Risk
Increased risk for other autoimmune diseases such as celiac disease (1-10%), Hashimoto's thyroiditis (15-30%), Addison's disease (0.5%), and pernicious anemia.